"Phenylcarbamates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Phenyl esters of carbamic acid or of N-substituted carbamic acids. Structures are similar to PHENYLUREA COMPOUNDS with a carbamate in place of the urea.
Below are MeSH descriptors whose meaning is more general than "Phenylcarbamates".
Below are MeSH descriptors whose meaning is more specific than "Phenylcarbamates".
This graph shows the total number of publications written about "Phenylcarbamates" by people in this website by year, and whether "Phenylcarbamates" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Phenylcarbamates" by people in Profiles.
Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity. Am J Emerg Med. 2014 Jul; 32(7):815.e3-4.
Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Saf. 2011 Jul 01; 34(7):533-44.
Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Pediatr Neurol. 2010 Jun; 42(6):396-403.
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2005 Mar 31; 352(13):1387; author reply 1387.
Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease. Clin Ther. 2004 Jul; 26(7):980-90.
Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am J Respir Crit Care Med. 1997 Apr; 155(4):1398-403.